Professional Documents
Culture Documents
Result Update
crore (up 4.8% YoY), while revenue from Europe region was at | 1,372 crore P a rticu la r Am o u n t
(up 12.3% YoY, flat in Euro terms). EBITDA in Q2FY20 was at | 695 crore (up Mark et C apitaliz ation ₹ 8466 C rore
Total D ebt (F Y 20) (₹ C rore) 6,763.9
60.8% YoY) with attendant EBITDA margins at 16.2% (up 538 bps YoY);
C as h & Inv. (F Y 20) (₹ C rore) 749.6
savings across all cost heads. APMEA EBIT margins rose 758 bps YoY to E V (₹ C rore) 14,480.6
13.9% while Europe continued to post a loss at EBIT level. Consequent 52 week H /L (₹) 182 / 74
consolidated PAT came in at | 200 crore, up 1.4x YoY. E quity capital ₹ 57.2 C rore
F ace value ₹1
Continued replacement strength, market share gain bodes well
Price chart
For ATL, APMEA (largely India) region formed ~68% of consolidated FY20
revenues, with Europe forming ~32%. In terms of channel mix, replacement 300 14,000
12,000
and OEM segmentation was at ~81:19, while among vehicle segments PV 200 10,000
8,000
and CV formed ~39% and ~49%, respectively. Domestically, the rebound 6,000
100
following lifting of lockdown restrictions has been quite strong, especially in 4,000
2,000
the replacement market (with all major segments reporting double-digit YoY 0 0
growth in Q2FY21), with outlook also healthy for the prevailing quarter. The
Nov-18
Nov-17
Nov-19
Nov-20
May-19
May-18
May-20
company has gained substantial ~500 bps market share in India PCR
category as of August 2020 on higher utilisation, expanded distribution ATL (LHS) Nifty (RHS)
footprint as well as benefits arising out of import restrictions. Bottoming out
The company said that strong volume gains in trucks segment is driven by increased goods movement along
with firmer freight rates and return of key segments like mining and road building
The company gained ~500 bps market share in India PCR and agri segments during April-August 2020, while TBR
market share gains were at > 300 bps. PCR market share now stands at ~24%
In India PCR, high utilisation (~85%), restriction on imports (forms ~15% of PCR category), improved mix and
dealer expansion (especially in rural areas) helped market share movement. The company believes that PCR
market share gains are sustainable
Bias CV tyres (TBB) growth has been higher than TBR growth during FY20 for the industry as well as for ATL due
to pressure on incomes of fleet operators. Radialisation levels have dipped to ~50% vs. ~55% earlier, however
they are seen continuing to move upwards in coming years
ATL launched motorcycle radial tyres (MCR) in India in Q2FY21, and these have garnered good response. The
segment is highly profitable (~25% margins)
ATL plans to launch Vredestein brand in India aftermarket in January 2021 to address opportunity presented by
import restriction in the high-end segment i.e. 17-24 inches
The company added Kia Motors as a customer in India and started serving the new Hyundai Creta
In Europe, market share gains in ultra-high performance (UHP) PCR tyres were at 12 bps, while those in TBR and
farm tyres were at ~25 bps each
The company is witnessing slow traction for winter tyres in Europe thus far amid renewed lockdowns in major
markets
Margin performance during the quarter was helped by good volume growth across segments along with lower
input costs and controlled fixed costs. For Q2FY21, India EBITDA margins were at ~19% vs 11.7% YoY, while
Europe EBITDA margins were at ~9% vs. 6.7% last year. Heavy depreciation outgo related to Hungary facility
impacted Europe EBIT performance in Q2FY21
ATL has managed to reduce fixed costs by >15% YoY in H1FY21. A portion of this reduction is sustainable (in
areas of rent negotiation, ad spends, etc)
Dutch specialisation programme would entail manpower reduction of 500 employees by the end of the year, with
benefits (savings of ~€ 40 million p.a.) to accrue from FY22E onwards. Better product mix, higher customer reach
(via expanded network) and higher utilisation levels along with improved cost competitiveness (cost of production
at ~ € 2.6/kg in Netherlands vs. < €1/kg in Hungary) as a result of the program is seen leading to margin and
return ratio improvement in Netherlands. Europe margins are seen rising to high teen levels in the next two years
Input costs (| per kg) during Q2FY21 – natural rubber 137, synthetic rubber 90, carbon black 58. Input costs are
set to increase ~5% QoQ in Q3FY21E and thereby challenge margins. The company has 45-60 days of rubber
inventory procured at lower cost, which would mitigate some of the impact
ATL said that the worst of the pricing decline in Europe is now behind
Digital product launches have led to expanded customer outreach as well as substantial cost savings
Others
Net debt has reduced by ~| 1,400 crore from FY20 to ~| 4,600 crore as of September 2020 end
The company reiterated that capex intensity is set to reduce going forward (FY21E India capex guidance at
~| 1,050 crore, FY22E guidance at | 1,600 crore; Europe capex guidance at ~€ 25-30 million p.a.). FCF generation
would be utilised towards further deleveraging actions
The company highlighted its desire to return to double digit return ratios in the next few years. With large part of
capex requirements now behind it, sweating assets at >90% utilisation levels would be a focus area
The payback period on the Andhra Pradesh greenfield capex (cost of ~| 3,800 crore) is at ~seven years, implying
targeted ~14% RoCE profile
The company has undertaken redesigning of India supply chain, and wants to focus on digitising it. going ahead
ATL added > 350 India dealers and > 200 Europe dealers in H1FY21
The company believes that large part of working capital improvements realised thus far in FY21 are sustainable
(%)
9,000
0.6 0
6,000
14,841
17,549
16,327
16,432
18,534
20,249
3,000 -5
-7.0
- -10
FY18 FY19 FY20 FY21E FY22E FY23E
Sales % growth
21,000
5,251
5,619
4,630
18,000
India revenues are seen growing at 7.9% CAGR over
(₹ crore)
15,000
FY20-23E. Europe sales are expected to grow at
12,000 6.6% CAGR in the aforesaid period
9,000
6,000
10,300
12,354
11,062
10,802
12,508
13,896
3,000
-
FY21E
FY22E
FY23E
FY18
FY19
FY20
India Europe
8.0
1,500 ~15% levels by FY23E. Savings of staff costs in
6.0 Netherlands is expected to push Europe margins
1,000 significantly higher
4.0
1,916
2,696
1,959
2,196
3,068
500 2.0
- -
FY19 FY20 FY21E FY22E FY23E
2.9
500 3 interest outgo
2.3
(%)
400
2
300
200
1
724
680
476
366
738
930
100
- -
FY18 FY19 FY20 FY21E FY22E FY23E
0.3 4
0.2
3
0.2 2
1
- -
FY18 FY19 FY20 FY21E FY22E FY23E
6,000
5,000 With peak capex levels a thing of the past, we
3,479
(₹ crore)
4,000
2,437
1,818
1,818
3,000
1,420
1,268
1,242
2,000
739
718
4,661
4,931
6,764
5,764
5,764
4,464
1,000
-
FY18 FY19 FY20 FY21E FY22E FY23E
Financial Summary
Exhibit 11: Profit and loss statement | crore Exhibit 12: Cash flow statement | crore
(Ye a r-e n d Ma rch ) F Y20 F Y21E F Y22E F Y23E (Ye a r-e n d Ma rch ) F Y20 F Y21E F Y22E F Y23E
T o ta l o p e ra tin g In co m e 16,327.0 16,432.2 18,534.3 20,248.9 P ro fit a fte r Ta x 476.4 366.4 738.2 930.0
G rowth (% ) -7.0 0.6 12.8 9.3 Add: D epreciation 1,138.1 1,314.6 1,408.6 1,569.3
R aw Material E xpens es 9,075.5 9,080.9 10,385.7 11,309.5 (Inc)/dec in C urrent As s ets 434.4 91.2 -593.7 -484.2
E m ployee E xpens es 2,482.2 2,472.2 2,319.4 2,460.8 Inc/(dec) in C L and P rovis ions 644.8 196.6 265.2 421.8
O ther E xpens es 2,853.7 2,683.0 3,133.1 3,410.3 C F fro m o p e ra tin g a ctivitie s 2693.8 1968.8 1818.4 2436.9
Total O perating E xpenditure 14,411.3 14,236.1 15,838.2 17,180.6 (Inc)/dec in Inves tm ents 0.0 0.0 0.0 0.0
E BIT DA 1,915.6 2,196.1 2,696.1 3,068.3 (Inc)/dec in F ixed As s ets -4,851.9 -1,267.5 -1,817.5 -717.5
G rowth (% ) -2.2 14.6 22.8 13.8 O thers 1,167.2 -39.2 165.9 126.1
C F fro m in ve stin g a ctivitie s -3684.7 -1306.7 -1651.6 -591.4
D epreciation 1,138.1 1,314.6 1,408.6 1,569.3
Is s ue/(B uy back ) of E quity 0.0 0.0 6.3 0.0
Interes t 280.8 459.4 403.5 358.0
Inc/(dec) in loan funds 1,833.3 -1,000.0 0.0 -1,300.0
O ther Incom e 46.9 103.8 102.9 102.4
D ividend paid & dividend tax -205.9 -114.4 -228.8 -286.0
P BT 543.6 520.0 986.9 1243.4
O thers -449.6 1,030.0 -26.3 -20.0
E xceptional item s 0.0 5.9 0.0 0.0
C F fro m fin a n cin g a ctivitie s 1177.8 -84.4 -248.8 -1606.0
Total Tax 67.2 153.6 248.7 313.3
Ne t C a sh flo w 186.9 577.7 -82.0 239.5
R e p o rte d P AT 476.4 366.4 738.2 930.0
O pening C as h 562.7 749.6 1,327.3 1,245.3
G rowth (% ) -29.9 -23.1 101.5 26.0
C lo sin g C a sh 749.6 1327.3 1245.3 1484.7
E P S (₹) 8.3 6.4 11.6 14.6 Source: Company, ICICI Direct Research
Source: Company, ICICI Direct Research
Exhibit 15: ICICI Direct coverage universe (Auto & Auto Ancillary)
Sector / Company CMP TP M Cap EPS (₹) P/E (x) EV/EBITDA (x) RoCE (%) RoE (%)
(₹) (₹) Rating (₹ Cr) FY20 FY21E FY22E FY20 FY21E FY22E FY20 FY21E FY22E FY20 FY21E FY22E FY20 FY21E FY22E
Apollo Tyre (APOTYR) 148 175 Buy 8,466 8.3 6.4 11.6 17.8 23.1 12.7 7.6 5.9 5.2 4.5 5.0 7.0 4.8 3.3 6.3
Ashok Leyland (ASHLEY) 84 90 Buy 24,588 0.8 0.3 2.5 103.0 316.3 33.9 22.6 28.1 14.5 4.5 2.3 9.2 4.7 1.1 9.4
Bajaj Auto (BAAUTO) 2,930 3,570 Buy 84,785 176.2 142.5 180.2 16.6 20.6 16.3 13.2 14.7 10.6 23.9 24.1 27.3 25.6 18.5 20.7
Bharat Forge (BHAFOR) 475 415 Hold 22,115 7.5 3.5 13.7 63.3 136.3 34.7 22.2 30.0 16.6 5.8 2.2 7.9 7.8 3.0 11.1
Eicher Motors (EICMOT) 2,100 2,470 Buy 57,246 67.0 46.6 71.3 31.3 45.1 29.5 23.2 29.1 19.9 17.3 11.5 15.4 18.3 11.6 15.4
Escorts (ESCORT) 1,250 1,460 Buy 15,323 39.6 59.5 71.0 31.6 21.0 17.6 21.3 13.8 11.5 16.2 15.3 15.3 14.2 14.0 14.5
Exide Industries (EXIIND) 165 180 Buy 14,025 9.7 6.3 8.9 11.8 18.0 12.9 10.1 12.5 9.7 15.7 10.3 13.5 13.4 8.2 10.7
Hero Moto (HERHON) 2,945 3,450 Buy 58,812 181.9 123.6 161.8 16.2 23.8 18.2 13.2 15.2 11.4 21.3 16.6 20.6 22.7 16.0 19.0
M&M (MAHMAH) 600 760 Buy 74,592 11.2 29.1 40.0 53.8 20.6 15.0 12.3 12.6 9.5 12.9 10.8 13.8 6.4 9.2 11.6
Maruti Suzuki (MARUTI) 7,100 6,335 Reduce 2,14,477 187.1 132.1 191.8 38.0 53.8 37.0 24.5 35.0 22.7 7.4 3.6 7.6 11.7 7.8 10.6
Minda Industries (MININD) 325 370 Hold 8,364 5.9 2.8 10.0 55.0 115.5 32.4 15.1 17.5 11.3 10.2 6.3 12.7 10.3 4.0 13.0
Tata Motors (TATMOT) 135 165 Buy 48,569 -33.3 -16.6 6.1 NM NM 22.1 5.1 4.8 3.5 1.3 2.8 6.4 -18.7 -10.6 3.7
Source: Bloomberg, ICICI Direct Research
RATING RATIONALE
ICICI Direct endeavors to provide objective opinions and recommendations. ICICI Direct assigns ratings to its
stocks according to their notional target price vs. current market price and then categorizes them as Buy, Hold,
Reduce and Sell. The performance horizon is two years unless specified and the notional target price is defined
as the analysts' valuation for a stock
Buy: >15%
Hold: -5% to 15%;
Reduce: -15% to -5%;
Sell: <-15%
ANALYST CERTIFICATION
I/We, Shashank Kanodia, CFA, MBA (Capital Markets), and Jaimin Desai, CA, Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect
our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. It is also confirmed that
above mentioned Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months and do not serve as an officer, director or employee of the companies
mentioned in the report.
ICICI Securities is one of the leading merchant bankers/ underwriters of securities and participate in virtually all securities trading markets in India. We and our associates might have investment banking and other business relationship
with a significant percentage of companies covered by our Investment Research Department. ICICI Securities generally prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the
securities or derivatives of any companies that the analysts cover.
Recommendation in reports based on technical and derivative analysis centre on studying charts of a stock's price movement, outstanding positions, trading volume etc as opposed to focusing on a company's fundamentals and, as
such, may not match with the recommendation in fundamental reports. Investors may visit icicidirect.com to view the Fundamental and Technical Research Reports.
Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein.
ICICI Securities Limited has two independent equity research groups: Institutional Research and Retail Research. This report has been prepared by the Retail Research. The views and opinions expressed in this document may or may
not match or may be contrary with the views, estimates, rating, target price of the Institutional Research.
The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained herein is strictly confidential and meant solely for the selected
recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would
endeavour to update the information herein on a reasonable basis, ICICI Securities is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent ICICI
Securities from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or ICICI Securities policies, in
circumstances where ICICI Securities might be acting in an advisory capacity to this company, or in certain other circumstances.
This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report and information herein
is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers
simultaneously, not all customers may receive this report at the same time. ICICI Securities will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting
and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who
must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient.
The recipient should independently evaluate the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. ICICI Securities accepts no liabilities
whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks
associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice.
ICICI Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months.
ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of managing or co-
managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction.
ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its associates or its analysts did not receive any compensation or other
benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ICICI Securities nor Research Analysts and their relatives have any material conflict of
interest at the time of publication of this report.
Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions.
ICICI Securities or its subsidiaries collectively or Research Analysts or their relatives do not own 1% or more of the equity securities of the Company mentioned in the report as of the last day of the month preceding the publication of
the research report.
Since associates of ICICI Securities are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this
report.
ICICI Securities may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Neither the Research Analysts nor ICICI Securities have been engaged in market making activity for the companies mentioned in the report.
We submit that no material disciplinary action has been taken on ICICI Securities by any Regulatory Authority impacting Equity Research Analysis activities.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or
use would be contrary to law, regulation or which would subject ICICI Securities and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in
all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.